Rajesh R. Parekh

Rajesh R. Parekh discloses dealings in Celldex Therapeutics, Inc. to SEC (Form 4). In total, 6 filings cover trades dated from 8 September 2008 to 22 September 2010.

In open-market terms, that means 1 purchase worth €116k on one side and 3 sales worth €448k on the other. On balance, insiders were net sellers of €332k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants. In 2010 alone, the filings show 1 purchase and no sales.

Most recently, on 22 September 2010, the filings show a share grant in Celldex Therapeutics, Inc. The latest purchase dates back some time: it was published 5,900 days ago, on 14 September 2010. Typically, a trade is published a median of 7 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.